Amended Annual Report (10-k/a)
October 28 2016 - 3:18PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-K/A
Amendment
No. 2
|
[X]
|
ANNUAL
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For
the fiscal year ended
June 30, 2012
|
|
[ ]
|
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
|
|
|
|
For
the transition period from _________ to ________
|
|
|
|
Commission
file number
: 333-168930
|
|
|
|
|
|
|
Nano
Mobile Healthcare, Inc.
|
(Exact
name of registrant as specified in its charter)
|
Nevada
|
93-0659770
|
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
3
Columbus Circle, 15
th
Floor
New
York, NY
|
10019
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number:
917-745-72022
|
|
Securities
registered under Section 12(b) of the Exchange Act:
|
Title
of each class
|
Name
of each exchange on which registered
|
none
|
not
applicable
|
Securities
registered under Section 12(g) of the Exchange Act:
|
Common
Stock, Par Value $0.001 per Share
|
|
(Title
of each class)
|
|
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
|
Yes
[ ]
No [
X]
|
|
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
|
Yes
[ ]
No [
X]
|
|
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days.
|
Yes
[X]
No [
]
|
|
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is
not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
|
Yes
[X]
No [
]
|
|
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" in Rule 12b-2 of the Exchange Act.
|
[
]
|
|
|
Accelerated
filer
|
[
]
|
|
[
]
|
|
|
Smaller
reporting company
|
[
X]
|
|
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
|
Yes
[ ]
No [
X]
|
|
|
|
State
the number of shares outstanding of each of the Registrant's classes of common stock, as of the latest practicable date. 80,025,000
issued and outstanding as of September 30, 2012.
|
|
|
|
|
DOCUMENTS
INCORPORATED BY REFERENCE:
None.
|
|
|
|
|
|
|
|
|
|
EXPLANATORY
NOTE
Nano
Mobile Healthcare, Inc. (the "Company") is filing this Amendment No.2 of Form 10-K/A (this "Amendment") to
amend its Annual Report on Form 10-K for the year ended June 30, 2012 (the "Original Form 10-K"), originally filed with
the Securities and Exchange Commission on October 15, 2012, and later amended on October 19, 2012. The purpose of this Amendment
is solely to correct a typographical error which appeared on the cover page of the Original Form 10-K, and was reproduced in the
Company’s amendment to the Original Form 10-K, which incorrectly identified the Company as a shell company. The Company
is making this Amendment to properly check the box that says “No,” the Company is not a shell company as defined in
Rule 12b-2 of the Exchange act.
No
revisions are being made to the Company's financial statements. This Amendment speaks as of the original filing date, does not
reflect events occurring after the filing of the Original Form 10-K or subsequent amendment, or modify or update those disclosures
that may be affected by subsequent events, and no other changes are being made to any other disclosure contained in the Original
Form 10-K.
PART
IV
ITEM
15. EXHIBITS, FINANCIAL STATEMENTS SCHEDULES
(a)
|
Financial
Statements and Schedules
|
Financial
Statements (See Item 8)
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
Nano
Mobile Healthcare, Inc.
By:
/s/
Joseph C. Peters
Joseph
C. Peters
President,
Chief Executive Officer, Principal Executive Officer,
Chief
Financial Officer, Principal Financial Officer,
Principal
Accounting Officer, and Director
October
28, 2016
Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.
By:
/s/
Joseph C. Peters
Joseph
C. Peters
President,
Chief Executive Officer, Principal Executive Officer,
Chief
Financial Officer, Principal Financial Officer,
Principal
Accounting Officer, and Director
October
28, 2016
By:
/s/
Tony van Bijleveld
Tony
van Bijleveld
Director
October
28, 2016
By:
/s/
Dr. Steven R. Steinhubl
Steven
R. Steinhubl
Director
October
28, 2016
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Apr 2023 to Apr 2024